759 results on '"Sattler, Martin"'
Search Results
152. Materiallösungen für die Leistungselektronik Bedeutung der Aufbau- und Verbindungstechnik
153. Inhibition of Propionibacterium acnes associated biofilm formation by Decanediol
154. Materials Solutions for Power Electronics Packaging Technology and its True Significance
155. Abstract 2912: The AP-1 transcription factor JunB promotes multiple myeloma cell proliferation, survival and drug resistance in the bone marrow microenvironment
156. Unique fractal evaluation and therapeutic implications of mitochondrial morphology in malignant mesothelioma
157. Kurzbibliographie
158. Using combination therapy to override stromal-mediated chemoresistance in mutant FLT3-positive AML: Synergism between FLT3 inhibitors, dasatinib/multi-targeted inhibitors, and JAK inhibitors: Novel combination therapy approaches to overriding stromal-mediated chemoresistance
159. Untersuchungen und Maßnahmen zur Vermeidung der Fahrzeugtüröffnung während des Seitenaufpralls
160. Correction: CBL Is Frequently Altered in Lung Cancers: Its Relationship to Mutations in MET and EGFR Tyrosine Kinases
161. Abstract A60: Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: Therapeutic implications
162. Inhibition of Wild-Type p53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097
163. Elektrische Antriebe im Kontext globaler Entwicklung und regionaler Differenzierung
164. Hybridisierung mit einer E-Achse für das 48-V-Bordnetz
165. Electric Axle for 48-V Electrical Hybrid Systems
166. EGFR-Targeted Therapeutics: Focus on SCCHN and NSCLC
167. Die Autoren
168. Rechtsextremismus in der Bundesrepublik
169. Cell Motility, Adhesion, Homing, and Migration Assays in the Studies of Tyrosine Kinases
170. Therapeutic Targeting of the Receptor Tyrosine Kinase Met
171. The AP-1 Transcription Factor JunB Promotes Multiple Myeloma (MM) Cell Proliferation, Survival and Drug Resistance in the Bone Marrow Microenvironment
172. Identification of Wee1 and IGF-1R As Novel Therapeutic Targets for Mutant RAS-Driven Acute Leukemia By Combinatory Chemical Screens
173. Upregulation of IGF1R by Mutant RAS in Leukemia and Potentiation of RAS Signaling Inhibitors by Small-Molecule Inhibition of IGF1R
174. Abstract 3383: JunB/AP-1 controls MM cell proliferation, survival and drug resistance in the bone marrow microenvironment
175. Knieluxation
176. Targeting Mcl-1 for multiple myeloma (MM) therapy: Drug-induced generation of Mcl-1 fragment Mcl-1128–350 triggers MM cell death via c-Jun upregulation
177. Using Small Molecules To Identify Critical Signaling Pathways Of Mutant N-RAS In Acute Leukemia Cells
178. Small Molecule Activators Of AMPK Block The Glycogen Production Required For Transformation Of Myeloid Leukemia Cells
179. 2 Fragen An...
180. Structure of a pseudokinase-domain switch that controls oncogenic activation of Jak kinases
181. Abstract 1734: Drug- induced generation of Mcl-1128-350 fragment triggers apoptosis in multiple myeloma cells through upregulation of c-Jun.
182. A tissue-engineered human dermal construct utilizing fibroblasts and transforming growth factor β1 to promote elastogenesis
183. Selective Akt Inhibitors Synergize with Tyrosine Kinase Inhibitors and Effectively Override Stroma-Associated Cytoprotection of Mutant FLT3-Positive AML Cells
184. The Role of the ABL1/YAP1/P73 Axis in Prevention of DNA Damage-Mediated Apoptosis in Multiple Myeloma
185. Targeting Mcl-1 for Multiple Myeloma (MM) Therapy: Drug-Induced Generation of Mcl-1 Fragment Mcl-1128–350 Triggers MM Cell Death Via c- Jun Upregulation
186. Deciphering the Critical Pathways of Mutant N-RAS in AML Using Small Molecule Inhibitors.
187. BCR-ABL Transformation Requires Glycogen Synthase 1 (GYS1) Expression for Cell Growth and Increased Glycogen Production
188. Rac2-MRC-cIII–generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors
189. Targeting JAK2 in the therapy of myeloproliferative neoplasms
190. Kinase Domain Mutations in JAK2V617F Confer Resistance to the Novel JAK2 Inhibitor Ruxolitinib
191. Targeting Rac2 - Mitochondrial Respiratory Chain Complex III Signaling to Prevent Genomic Instability in Leukemia Stem and Progenitor Cells
192. Reversible Resistance Induced by FLT3 Inhibition: A Novel Resistance Mechanism in Mutant FLT3-Expressing Cells
193. Aconitase Regulation of Erythropoiesis Correlates with a Novel Licensing Function in Erythropoietin-Induced ERK Signaling
194. The role of the c-Met pathway in lung cancer and the potential for targeted therapy
195. Impact of collagen crosslinking on the second harmonic generation signal and the fluorescence lifetime of collagen autofluorescence
196. Mutant Cbl proteins as oncogenic drivers in myeloproliferative disorders
197. Mitochondrial Respiratory Chain Complex III Causes Genomic Instability In CML-CP.
198. The JAK2V617F Oncogene, Associated with Myeloproliferative Neoplasms, Requires Expression of Inducible Phosphofructokinase/Fructose Bisphosphatase 3 for Cell Growth and Increased Metabolic Activity
199. Novel Oncogenic Mutations of CBL in Human Acute Myeloid Leukemia That Activate Growth and Survival Pathways Depend on Increased Metabolism
200. CBL Is Frequently Altered in Lung Cancers: Its Relationship to Mutations in MET and EGFR Tyrosine Kinases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.